Follow-The-Filings

Security · featured owners

ARTV Artiva Biotherapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.1%
  • $26M
  • 2 new

ARTV (Artiva Biotherapeutics Inc.) is held in 2 featured 13F books as of 2026 Q2. Nathan Fischel - Dafna Capital Management is the largest tracked holder by portfolio weight (0.12%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel new 0.12%
  2. Andreas Halvorsen new 0.07%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Andreas Halvorsen - Viking Global Investors 2026 Q2 0.07% New 0.07% 2,604,166 $25M history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.12% New 0.12% 67,101 $651K history

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Net income -$65.37M -$83.86M

Balance sheet

Metric FY2024 FY2025
Total current assets $188.63M $112.67M
Total non-current assets * $20.95M $18.27M
Total assets $209.58M $130.94M
Total current liabilities $12.25M $13.09M
Total non-current liabilities * $10.69M $7.88M
Total equity $186.64M $109.97M

Cash flow

Metric FY2024 FY2025
Cash from operations -$55.03M -$76.75M
Cash from investing -$120.46M $63.41M
Cash from financing $162.23M $0.009M
Net change in cash -$13.27M -$13.33M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders

Q2 2026

period archive